Carbohydrate Antigen 125-guided Therapy in Heart Failure
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 360 participants.
Also called NCT02008110
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 360 participants
- Sponsor
- Registry
-
NCT02008110 -
2011-000414-20
-
- Other papers using this trial's data
- Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Spain
- Registry status
- Completed
Technical summary
Registry record NCT02008110. Randomized; single masking; primary purpose treatment. Start 2011-12 (registry gives no type); primary completion 2014-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Carbohydrate Antigen 125-guided Therapy in Heart Failure
- Acronym
- CHANCE-HF
- Condition
- Heart Failure
- Intervention (Drug)
- CA125 guided strategy
- Intervention (Drug)
- CA125 guided strategy
- Intervention (Drug)
- CA125 guided strategy
- Intervention (Other)
- CA125 guided strategy
- Intervention (Drug)
- Standard treatment strategy
- Intervention (Drug)
- CA125 guided strategy
- Lead sponsor
- Fundación para la Investigación del Hospital Clínico de Valencia
- Collaborator
- Ministerio de Sanidad, Servicios Sociales e Igualdad
Record details
- Record id
cardio:ct-nct02008110- Content hash
6d10e4a34f1baf628b60955f96c7127755c509a971b0e9766e9ddad0b7e1412f